Characteristic | participants | HR (95%CI) P for interacion | β(95%CI) P for interacion |
---|---|---|---|
Age(years) | Â | 0.6636 | 0.5920 |
  < 60(years) | 218 | 0.859 (0.747, 0.988) | -0.308 (-0.881, 0.264) |
  ≥ 60(years) | 744 | 0.829 (0.751, 0.914) | -0.466 (-0.831, -0.102) |
Gender | Â | 0.8543 | 0.6664 |
 Male | 670 | 0.844 (0.766, 0.930) | -0.480 (-0.868, -0.092) |
 Female | 292 | 0.831 (0.722, 0.956) | -0.304 (-1.026, 0.417) |
Urinary occult blood | Â | 0.1975 | 0.5015 |
 No | 652 | 0.874 (0.786, 0.972) | -0.380 (-0.760, -0.001) |
 Yes | 310 | 0.788 (0.697, 0.892) | -0.566 (-1.080, -0.052) |
BMI(kg/m2) | Â | 0.5280 | 0.1642 |
  < 23.5 | 492 | 0.825 (0.737, 0.924) | -0.715 (-1.168, -0.262) |
  ≥ 23.5 | 470 | 0.866 (0.775, 0.968) | -0.304 (-0.752, 0.144) |
SBP(mmHg) | Â | 0.0276 | 0.3823 |
  < 140 | 514 | 0.741 (0.651, 0.843) | -0.317 (-0.740, 0.107) |
  ≥ 140 | 448 | 0.871 (0.791, 0.959) | -0.536 (-0.961, -0.111) |
UPCR (g/gCr) | Â | 0.0145 | 0.2201 |
  < 0.5 | 458 | 0.683 (0.548, 0.851) | -0.217 (-0.742, 0.308) |
  ≥ 0.5 | 504 | 0.903 (0.832, 0.981) | -0.637 (-1.075, -0.199) |
Etiology of CKD | Â | 0.3714 | 0.9391 |
 Diabetic nephropathy | 44 | 0.781 (0.692, 0.881) | -0.498 (-1.049, 0.053) |
 Nephrosclerosis | 85 | 0.943 (0.786, 1.130) | -0.391 (-0.846, 0.064) |
 Glomerulonephritis | 178 | 0.799 (0.605, 1.055) | -0.566 (-1.227, 0.096) |
 Other | 155 | 0.868 (0.613, 1.230) | -0.338 (-0.990, 0.314) |
Use of RAAS inhibitor | Â | 0.9565 | 0.7207 |
 No | 336 | 0.830 (0.712, 0.967) | -0.496 (-0.974, -0.018) |
 Yes | 626 | 0.834 (0.761, 0.913) | -0.404 (-0.789, -0.018) |
Hypertension | Â | 0.0173 | 0.6052 |
 No | 96 | 0.435 (0.257, 0.734) | -0.716 (-1.657, 0.225) |
 Yes | 866 | 0.842 (0.775, 0.915) | -0.457 (-0.823, -0.091) |
History of CVD | Â | 0.0978 | 0.1901 |
 No | 704 | 0.862 (0.787, 0.944) | -0.323 (-0.706, 0.059) |
 Yes | 258 | 0.755 (0.652, 0.874) | -0.694 (-1.212, -0.175) |
Diabetes | Â | 0.7648 | 0.1948 |
 No | 598 | 0.819 (0.728, 0.922) | -0.592 (-1.005, -0.179) |
 Yes | 364 | 0.837 (0.759, 0.923) | -0.208 (-0.697, 0.280) |
Use of calcium channel blocker | Â | 0.2353 | 0.7644 |
 No | 503 | 0.791 (0.698, 0.897) | -0.474 (-0.901, -0.047) |
 Yes | 459 | 0.869 (0.783, 0.965) | -0.398 (-0.821, 0.024) |
Use of diuretics | Â | 0.0271 | 0.3428 |
 No | 650 | 0.903 (0.811, 1.005) | -0.615 (-1.010, -0.220) |
 Yes | 312 | 0.761 (0.676, 0.856) | -0.329 (-0.854, 0.195) |
ALB(g/dL) | Â | 0.8595 | 0.1032 |
 < 4 | 465 | 0.837 (0.768, 0.911) | -0.716 (-1.129, -0.303) |
  ≥ 4 | 497 | 0.852 (0.711, 1.021) | -0.280 (-0.718, 0.159) |